Although the optimal dose of radiation in combination with CAR T-cell therapy is under investigation, early preclinical and clinical evidence suggests that a rapid (hypofractionated) course of radiation can avoid lymphopenia and also result in the recruitment of dendritic cells, priming of anti-tumor CD8+ T cells, and a relatively low number of infiltrating regulatory T cells. Here, CD8A is linked to neoplasm.